Davenport_Lab

Our latest review of approved & investigational drugs including in combination with SGLT2 inhibitors now in Nature Cardiovascular Research:Current and future strategies for targeting the endothelin pathway in cardiovascular disease nature.com/articles/s4416… rdcu.be/dp7Q8

@Dr_MLHalls Thank you Michelle

@DavenportLab Congratulations Anthony!! 👏

Congratulations to our PI, Professor Anthony Davenport who has been awarded Honorary Fellowship by the British Pharmacological Society. bps.ac.uk/publishing/blo…

Congratulations to our PI, Prof Anthony Davenport who has been ranked one of the 2020 highest cited researchers (top 1% by citations for field and year in Web of Science) for two consecutive years...@Catz_Cambridge @Cambridge_Uni recognition.webofscience.com/awards/highly-…

A survey has revealed that 40% of early career researchers funded by charities like @TheBHF have considered leaving research over funding concerns. @hmtreasury & @RishiSunak need to support #ResearchAtRisk. I don’t want to hang up my lab coat for good. bit.ly/31MCeOE

Our latest paper could help explain why age is major risk factor for dying from COVID-19, with people over 70 years at greatest risk, and why the disease can cause heart complications in severe cases. sciencedirect.com/science/articl… @Cambridge_Uni @Catz_Cambridge

Dagger to the heart: Genes encoding ACE2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes. @Cambridge_Uni @Catz_Cambridge biorxiv.org/content/10.110…

Check out our latest paper in Nature drug discovery on advances in the GPCR-targeted peptide therapeutics...@Catz_Cambridge @Cambridge_Uni nature.com/articles/s4157…

Our latest paper where we showed for the first time the metabolism of apelin in human and identified novel metabolites has been published. Thanks to everyone who contributed to it. @Cambridge_Uni @Catz_Cambridge nature.com/articles/s4159…

It’s the final day and we’re starting off with a symposium on our favourite things - GPCRs! #Pharmacology2019 @BritPharmSoc

All set for day 2! #Pharmacology2019 @BritPharmSoc

Our PhD students, Mene, Tom and Robyn, have been busy presenting their work at #Pharmacology2019 @BritPharmSoc @Cambridgecardio @Cambridge_Uni

Ready to go at the first day of #pharmacology2019 ! @BritPharmSoc

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G Protein Biased Ligands at the Apelin Receptor. zpr.io/tPA9f Peptides #GPCR #signaling #pharmacology

A fantastic two days at @BSCResearch Autumn Meeting 2019! Very interesting and inspiring talks! Our PhD students Tom and Robyn presented their work at the poster session. Congratulations to Robyn for winning a prize for her poster! @Cambridge_Uni @Catz_Cambridge @TheBHF

Congratulations to our group leader Dr Anthony Davenport on his graduation as Doctor of Science today!! Very well deserved, we're all very proud 🥳🥳🥳 @Cambridge_Uni @Catz_Cambridge

Well done to our PhD student, Robyn, who completed the BHF London to Brighton 54-mile bike ride yesterday! She was part of a group of BHF-funded Cambridge PhD students, who have collectively raised over £1,000! @Cambridgecardio @Cambridge_Uni @Catz_Cambridge

Two of our PhD students, Tom and Robyn, and rotation student, Elisabeth, presenting their work at the poster session at #BASBSCRSpring2019 meeting @BSCResearch @britathsoc @Cambridgecardio - some great talks over the last two days!

Parenting tips from the cat... twitter.com/Mr_Meowwwgi/st…

Well done all!

Check out our latest paper on a novel G protein biased apelin agonist which has beneficial effects in pulmonary hypertension doi.org/10.1111/bph.14…. @Cambridge_Uni @Catz_Cambridge